Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1319 |
|
| Actual shortage: | 60 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1223 (93%) | |
Discontinuation Reports |
287 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 283 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
210 (13%) |
|
Overdue reports |
27 (44%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-MONTELUKAST FC | 10MG | TABLET | Avoided shortage | 2017-08-11 | 2017-09-07 | 18866 |
| PMS-MONTELUKAST FC | 10MG | TABLET | Resolved | 2017-12-07 | 2018-03-11 | 32065 |
| PMS-MONTELUKAST FC | 10MG | TABLET | Resolved | 2018-03-19 | 2018-04-19 | 43348 |
| PMS-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2019-05-09 | 2019-06-11 | 83696 |
| PMS-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2022-03-04 | 2022-06-23 | 156105 |
| PMS-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2023-06-09 | 2023-08-07 | 194530 |
| PMS-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2017-09-19 | 2018-06-07 | 22792 |
| PMS-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2024-08-02 | 2024-09-30 | 234387 |
| PMS-NABILONE | 1.0MG | CAPSULE | Resolved | 2019-03-01 | 2019-07-29 | 77191 |
| PMS-NABILONE | 0.5MG | CAPSULE | Resolved | 2019-03-01 | 2019-07-29 | 77195 |
| PMS-NABILONE | 0.5MG | CAPSULE | Resolved | 2019-06-28 | 2019-07-29 | 87983 |
| PMS-NABILONE | 0.5MG | CAPSULE | Resolved | 2017-04-04 | 2019-01-25 | 5505 |
| PMS-NABILONE | 1.0MG | CAPSULE | Resolved | 2017-04-04 | 2019-01-25 | 5508 |
| PMS-NABILONE | 0.5MG | CAPSULE | Resolved | 2017-09-08 | 2019-01-25 | 21676 |
| PMS-NABILONE | 1.0MG | CAPSULE | Resolved | 2017-09-08 | 2019-01-25 | 21679 |
| PMS-NAPROXEN | 500MG | SUPPOSITORY | Resolved | 2017-04-07 | 2020-06-10 | 6142 |
| PMS-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-07 | 2020-06-10 | 6145 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-20 | 2017-06-09 | 7444 |
| PMS-NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-20 | 2017-07-19 | 7447 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-20 | 2017-12-18 | 7450 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4993 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4990 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
| ACET CODEINE 30 | 300MG 30MG | TABLET | Discontinued | 2018-02-22 | 2018-07-23 | 40586 |
| ACET CODEINE 60 | 300MG 60MG | TABLET | Discontinued | 2019-01-16 | 2019-01-17 | 72608 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 15MG 8MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117751 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25698 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137982 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137986 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137995 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137992 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137998 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 138001 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Discontinued | 2020-06-16 | 2020-06-16 | 118017 |
| EGOZINC-HC | 0.5% 0.5% | OINTMENT | Discontinued | 2020-06-15 | 2021-10-27 | 117754 |